Regeneron (REGN) Says EYLEA Clinically Equivalent to Lucentis Following VIEW 1, 2 Phase 3s

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 5/26/2022

1. NVDA
2. SNOW
3. SPLK
4. NTNX
5. WSM
6. ENS
7. DXC
8. MDT
9. DKS
10. TWTR

Go back to Regeneron (REGN) Says EYLEA Clinically Equivalent to Lucentis Following VIEW 1, 2 Phase 3s
Regeneron (NASDAQ: REGN) Delayed: 690.88 --0 (-0%)
Previous Close $690.88    52 Week High $592.36 
Open $690.88    52 Week Low $325.35 
Day High $690.88    P/E 181.33 
Day Low $690.88    EPS $3.81 
Volume 40